Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001753926-25-001357·Ionic Ventures, LLC
Schedule 13G ownership disclosure
PROPANC BIOPHARMA INC
Common Stock, par value $0.001 per share · CUSIP: 74346N701
Event date: 2025-08-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ionic Ventures, LLC
Shares: 1,257,622.00 · Class: 9.9%
- Ionic Management, LLC
Shares: 1,257,622.00 · Class: 9.9%
- Brendan O'Neil
Shares: 1,257,622.00 · Class: 9.9%
- Keith Coulston
Shares: 1,257,622.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-001357
- Form type
- SCHEDULE 13G
- Filer
- Ionic Ventures, LLC
- CIK
- CIK 1769419
- Filed
- Aug 19, 2025
- Reporting period
- Aug 14, 2025
- Description
- Schedule 13G beneficial ownership